1-9 of 9
Yang Liu
Close
Sort by
Journal Articles

TRIM21 enhances bortezomib sensitivity in multiple myeloma by halting prosurvival autophagy

Clinical Trials & Observations
Jing Chen, Wen Cao, Xi Huang, Qingxiao Chen, Shuting Ye, Jianwei Qu, Yang Liu, Xing Guo, Shunnan Yao, Enfan Zhang, Jingsong He, Anqi Li, Li Yang, Zhen Cai
Journal: Blood Advances
Blood Adv (2023) 7 (19): 5752–5770.
https://doi.org/10.1182/bloodadvances.2022008241
Published: 2023
Includes: Supplemental data
Journal Articles

Dual targeting of CDK4/6 and Bcl-2 exhibits a potent antitumor effect on mantle cell lymphoma

Yuxuan Che, Yang Liu, Yijing Li, Joseph M. McIntosh, Alexa Jordan, Fangfang Yan, Wei Wang, Lei Nie, Heng-Huan Lee, Jingling Jin, Yixin Yao, Zhongming Zhao, Vivian Changying Jiang, Michael Wang
Journal: Blood Advances
Blood Adv (2023) 7 (14): 3361–3365.
https://doi.org/10.1182/bloodadvances.2022008954
Published: 2023
Includes: Supplemental data
Journal Articles

CRISPR/Cas9 genome-edited universal CAR T cells in patients with relapsed/refractory lymphoma

Yelei Guo, Chuan Tong, Liping Su, Wenying Zhang, Hejin Jia, Yang Liu, Qingming Yang, Zhiqiang Wu, Yao Wang, Weidong Han
Journal: Blood Advances
Blood Adv (2022) 6 (8): 2695–2699.
https://doi.org/10.1182/bloodadvances.2021006232
Published: 2022
Includes: Supplemental data
Journal Articles

Zanubrutinib monotherapy for relapsed or refractory non-germinal center diffuse large B-cell lymphoma

Clinical Trials & Observations
Haiyan Yang, Bing Xiang, Yuqin Song, Huilai Zhang, Weili Zhao, Dehui Zou, Fangfang Lv, Wei Guo, Aichun Liu, Caixia Li, Ziwen Tan, Yang Liu, Lina Fu, Haiyi Guo, William Novotny, Jane Huang, Yufu Li
Journal: Blood Advances
Blood Adv (2022) 6 (6): 1629–1636.
https://doi.org/10.1182/bloodadvances.2020003698
Published: 2022
Includes: Supplemental data
Journal Articles

Cost-effectiveness of eltrombopag vs intravenous immunoglobulin for the perioperative management of immune thrombocytopenia

Manraj N. Kaur, Donald M. Arnold, Nancy M. Heddle, Richard J. Cook, Cyrus Hsia, Mark Blostein, Erin Jamula, Michelle Sholzberg, Yulia Lin, Jeannine Kassis, Loree Larratt, Alan Tinmouth, Julie Carruthers, Na Li, Yang Liu, Feng Xie
Journal: Blood Advances
Blood Adv (2022) 6 (3): 785–792.
https://doi.org/10.1182/bloodadvances.2021005627
Published: 2022
Includes: Supplemental data
Journal Articles

Sequential different B-cell antigen–targeted CAR T-cell therapy for pediatric refractory/relapsed Burkitt lymphoma

Clinical Trials & Observations
Ying Liu, Biping Deng, Bo Hu, Wenqun Zhang, Qing Zhu, Yang Liu, Shan Wang, Pei Zhang, Ying Yang, Junhan Yang, Qinlong Zheng, Xinjian Yu, Zifen Gao, Chunju Zhou, Wei Han, Jing Yang, Ling Jin, Chunrong Tong, Alex H. Chang, Yonghong Zhang
Journal: Blood Advances
Blood Adv (2022) 6 (3): 717–730.
https://doi.org/10.1182/bloodadvances.2021004557
Published: 2022
Includes: Supplemental data
Journal Articles

Outcomes of patients with limited-stage aggressive large B-cell lymphoma with high-risk cytogenetics

Clinical Trials & Observations
Pallawi Torka, Shalin K. Kothari, Suchitra Sundaram, Shaoying Li, L. Jeffrey Medeiros, Emily C. Ayers, Daniel J. Landsburg, David A. Bond, Kami J. Maddocks, Anshu Giri, Brian Hess, Luu Q. Pham, Ranjana Advani, Yang Liu, Stefan Klaus Barta, Julie M. Vose, Michael C. Churnetski, Jonathon B. Cohen, Madelyn Burkart, Reem Karmali, Joanna Zurko, Amitkumar Mehta, Adam J. Olszewski, Sarah Lee, Brian T. Hill, Timothy F. Burns, Frederick Lansigan, Emma Rabinovich, David Peace, Adrienne Groman, Kristopher Attwood, Francisco J. Hernandez-Ilizaliturri
Journal: Blood Advances
Blood Adv (2020) 4 (2): 253–262.
https://doi.org/10.1182/bloodadvances.2019000875
Published: 2020
Journal Articles

Nfe2 is dispensable for early but required for adult thrombocyte formation and function in zebrafish

Megan S. Rost, Ilya Shestopalov, Yang Liu, Andy H. Vo, Catherine E. Richter, Sylvia M. Emly, Francesca G. Barrett, David L. Stachura, Michael Holinstat, Leonard I. Zon, Jordan A. Shavit
Journal: Blood Advances
Blood Adv (2018) 2 (23): 3418–3427.
https://doi.org/10.1182/bloodadvances.2018021865
Published: 2018
Includes: Multimedia, Supplemental data
Journal Articles

An aptamer-based targeted delivery of miR-26a protects mice against chemotherapy toxicity while suppressing tumor growth

Toshihiko Tanno, Peng Zhang, Christopher A. Lazarski, Yang Liu, Pan Zheng
Journal: Blood Advances
Blood Adv (2017) 1 (15): 1107–1119.
https://doi.org/10.1182/bloodadvances.2017004705
Published: 2017
Includes: Supplemental data